BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23662991)

  • 1. Analysis of activation-induced cytidine deaminase mRNA levels in patients with chronic lymphocytic leukemia with different cytogenetic status.
    Gelmez MY; Teker AB; Aday AD; Yavuz AS; Soysal T; Deniz G; Aktan M
    Leuk Lymphoma; 2014 Feb; 55(2):326-30. PubMed ID: 23662991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of AID, Dicer, and Drosha Expressions in Patients with Chronic Lymphocytic Leukemia.
    Gelmez MY; Coskunpinar E; Saracoglu B; Deniz G; Aktan M
    Immunol Invest; 2017 Jul; 46(5):433-446. PubMed ID: 28388279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.
    Marantidou F; Dagklis A; Stalika E; Korkolopoulou P; Saetta A; Anagnostopoulos A; Laoutaris N; Stamatopoulos K; Belessi C; Scouras Z; Patsouris E
    Blood Cells Mol Dis; 2010 Apr; 44(4):262-7. PubMed ID: 20117026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules.
    Dickinson JD; Gilmore J; Iqbal J; Sanger W; Lynch JC; Chan J; Bierman PJ; Joshi SS
    Leuk Lymphoma; 2006 Feb; 47(2):231-44. PubMed ID: 16321852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia.
    Hancer VS; Kose M; Diz-Kucukkaya R; Yavuz AS; Aktan M
    Leuk Lymphoma; 2011 Jan; 52(1):79-84. PubMed ID: 21133730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
    Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
    Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation.
    Oppezzo P; Vuillier F; Vasconcelos Y; Dumas G; Magnac C; Payelle-Brogard B; Pritsch O; Dighiero G
    Blood; 2003 May; 101(10):4029-32. PubMed ID: 12521993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20.
    Herold T; Jurinovic V; Mulaw M; Seiler T; Dufour A; Schneider S; Kakadia PM; Feuring-Buske M; Braess J; Spiekermann K; Mansmann U; Hiddemann W; Buske C; Bohlander SK
    Genes Chromosomes Cancer; 2011 Jul; 50(7):546-58. PubMed ID: 21500311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia.
    Zaprazna K; Reblova K; Svobodova V; Radova L; Bystry V; Baloun J; Durechova K; Tom N; Loja T; Buresova M; Stranska K; Oltova A; Doubek M; Atchison ML; Trbusek M; Malcikova J; Pospisilova S
    Ann Hematol; 2019 Feb; 98(2):423-435. PubMed ID: 30368590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
    Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
    Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia.
    Heintel D; Kroemer E; Kienle D; Schwarzinger I; Gleiss A; Schwarzmeier J; Marculescu R; Le T; Mannhalter C; Gaiger A; Stilgenbauer S; Döhner H; Fonatsch C; Jäger U;
    Leukemia; 2004 Apr; 18(4):756-62. PubMed ID: 14961036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocations as a mechanism for homozygous deletion of 13q14 and loss of the ATM gene in a patient with B-cell chronic lymphocytic leukemia.
    Herholz H; Kern W; Schnittger S; Haferlach T; Dicker F; Haferlach C
    Cancer Genet Cytogenet; 2007 Apr; 174(1):57-60. PubMed ID: 17350468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia.
    McCarthy H; Wierda WG; Barron LL; Cromwell CC; Wang J; Coombes KR; Rangel R; Elenitoba-Johnson KS; Keating MJ; Abruzzo LV
    Blood; 2003 Jun; 101(12):4903-8. PubMed ID: 12586616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.
    Fabbri M; Bottoni A; Shimizu M; Spizzo R; Nicoloso MS; Rossi S; Barbarotto E; Cimmino A; Adair B; Wojcik SE; Valeri N; Calore F; Sampath D; Fanini F; Vannini I; Musuraca G; Dell'Aquila M; Alder H; Davuluri RV; Rassenti LZ; Negrini M; Nakamura T; Amadori D; Kay NE; Rai KR; Keating MJ; Kipps TJ; Calin GA; Croce CM
    JAMA; 2011 Jan; 305(1):59-67. PubMed ID: 21205967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions.
    Patten PE; Chu CC; Albesiano E; Damle RN; Yan XJ; Kim D; Zhang L; Magli AR; Barrientos J; Kolitz JE; Allen SL; Rai KR; Roa S; Mongini PK; MacCarthy T; Scharff MD; Chiorazzi N
    Blood; 2012 Dec; 120(24):4802-11. PubMed ID: 23071276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
    Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
    Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the pathogenesis of chronic lymphocytic leukemia.
    Klein U; Dalla-Favera R
    Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease.
    Palacios F; Moreno P; Morande P; Abreu C; Correa A; Porro V; Landoni AI; Gabus R; Giordano M; Dighiero G; Pritsch O; Oppezzo P
    Blood; 2010 Jun; 115(22):4488-96. PubMed ID: 20233972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
    Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP
    Cancer; 2008 Mar; 112(6):1296-305. PubMed ID: 18246537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.